Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Blood Clots Are Rapidly Assembled Hemodynamic Sensors: Flow Arrest Triggers Intraluminal Thrombus Contraction.

Blood

English

Desmopressin and Super Platelets

English

Blood Consult: Treating Del(5q) Myelodysplastic Syndromes

English

Independently Acquired Biallelic JAK2 Mutations Are Present in a Minority of Patients With Essential Thrombocythemia

English

Leukemic Phase of ALK-positive Anaplastic Large Cell Lymphoma

English

AAML0523: A Report From the Children's Oncology Group on the Efficacy of Clofarabine in Combination With Cytarabine in Pediatric Patients With Relapsed Acute Myeloid Leukemia

English

Patient Preferences for Stopping Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

English

EVI-1 Oncogene Expression Predicts Survival in Chronic-Phase CML Patients Resistant to Imatinib Treated With Second-Generation Tyrosine Kinase Inhibitors

English

Phase 1b Study of Venetoclax-Obinutuzumab in Previously Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia

English

Reduction of the Six-Minute Walk Distance in Children With Sickle Cell Disease Is Correlated With Silent Infarct: Results From a Cross-Sectional Evaluation in a Single Center in Belgium.

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Blood Clots Are Rapidly Assembled Hemodynamic Sensors: Flow Arrest Triggers Intraluminal Thrombus Contraction.

Desmopressin and Super Platelets

Blood Consult: Treating Del(5q) Myelodysplastic Syndromes

Independently Acquired Biallelic JAK2 Mutations Are Present in a Minority of Patients With Essential Thrombocythemia

Leukemic Phase of ALK-positive Anaplastic Large Cell Lymphoma

AAML0523: A Report From the Children's Oncology Group on the Efficacy of Clofarabine in Combination With Cytarabine in Pediatric Patients With Relapsed Acute Myeloid Leukemia

Patient Preferences for Stopping Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

EVI-1 Oncogene Expression Predicts Survival in Chronic-Phase CML Patients Resistant to Imatinib Treated With Second-Generation Tyrosine Kinase Inhibitors

Phase 1b Study of Venetoclax-Obinutuzumab in Previously Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia

Reduction of the Six-Minute Walk Distance in Children With Sickle Cell Disease Is Correlated With Silent Infarct: Results From a Cross-Sectional Evaluation in a Single Center in Belgium.